Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03086343
Brief Title: A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs ( SELECT-CHOICE ) (SELECT-CHOICE)

First Submitted : March 20, 2017
First Submitted that Met QC Criteria : March 20, 2017
First Posted : March 22, 2017

Last Update Submitted that Met QC Criteria : March 20, 2019
Last Update Posted : March 22, 2019